FDA approves first treatment for sexual desire disorder
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women.
Million Hearts launches annual blood pressure control challenge
- Details
- Written by CDC
- Category: Health News
Washington, DC - The U.S. Department of Health and Human Services today launched an annual challenge designed to identify and honor clinicians and health care teams that have helped their patients control high blood pressure and prevent heart attacks and strokes.
Just 1 in 10 are referred for cardiac rehab after treatment for heart failure
- Details
- Written by Rachel Champeau
- Category: Health News
Los Angeles, California - Only 1 in 10 heart failure patients is referred to a cardiac rehabilitation program after being hospitalized, despite strong evidence that such exercise programs improve quality of life and reduce the likelihood of future hospitalizations.
Are Vitamin E supplements healthy or harmful?
- Details
- Written by Dr. John Swartzberg
- Category: Health News
Berkeley, California - t’s been nearly a century since UC Berkeley researchers discovered vitamin E. Since then, many studies have looked at the potential health benefits of this antioxidant, which supplement makers (and some researchers) predicted would help prevent cancer, heart disease and Alzheimer’s disease, help maintain eyesight and keep skin glowing.
Speedy treatment of stroke patients with new clot retrieval device vastly improves outcomes
- Details
- Written by Kim Irwin
- Category: Health News
Los Angeles, California - In the treatment of stroke patients, time really is brain. A few minutes can mean the difference between patients living independently or suffering debilitating disabilities.
Corrected Protein Structure Reveals Drug Targets for Cancer, Neurodegenerative Diseases
- Details
- Written by Heather Buschman, PhD
- Category: Health News
San Diego, California - Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death. When it goes awry, a number of diseases may result. In a study published August 13 in Cell Reports, researchers at University of California, San Diego School of Medicine reveal a more accurate structure of PKC, providing new targets for fine-tuning the enzyme’s activity as needed to improve human health.
Page 3127 of 3785